Stock SLS SELLAS LIFE SCIENCES GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News SELLAS Life Sciences Group, Inc.

Equities

SLS

US81642T2096

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
1.29 USD +0.78% Intraday chart for SELLAS Life Sciences Group, Inc. -4.44% +21.70%
May. 01 SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level CI
Apr. 29 SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
AQ
SELLAS Life Sciences Group, Inc. Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level
CI
SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study
AQ
SELLAS Life Sciences Group, Inc. Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study
CI
North American Morning Briefing : Powell Awaited -2-
DJ
SELLAS Life Sciences Reports Full Year 2023 Financial Results and Provides Corporate Update
AQ
SELLAS Life Sciences Group, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : SELLAS Life Sciences Group, Inc. - Special Call
SELLAS Announces Positive Topline Data from the Phase 2a Study of SLS009 in r/r AML and Provides Steering Committee Update on Phase 3 REGAL Study
AQ
SELLAS Life Sciences Group, Inc. Announces Positive Topline Data from the Phase 2a Study of Sls009 in r/r AML
CI
SELLAS Life Sciences to Host Corporate Update Call on March 26, 2024, at 8:15 am ET
AQ
Sector Update: Health Care Stocks Ease Late Afternoon
MT
Top Midday Decliners
MT
Sector Update: Health Care Stocks Softer Friday Afternoon
MT
Sellas Life Sciences Launches $20 Million Direct Offering, Private Placement -- Shares Fall
MT
SELLAS Life Sciences Group Announces $20 Million Registered Direct Offering and Concurrent Private Placement Priced At-the-Market Under Nasdaq Rules
AQ
SELLAS Life Sciences Group, Inc. announced a financing transaction
CI
SELLAS Life Sciences : Material Event - Form 8-K
PU
SELLAS Announces Executive Leadership Reorganization and Prioritization of Commercialization Partnerships
AQ
SELLAS Life Sciences Group, Inc. Announces Executive Changes
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLS Stock
  4. News SELLAS Life Sciences Group, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW